JP2000302661A - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JP2000302661A JP2000302661A JP11112972A JP11297299A JP2000302661A JP 2000302661 A JP2000302661 A JP 2000302661A JP 11112972 A JP11112972 A JP 11112972A JP 11297299 A JP11297299 A JP 11297299A JP 2000302661 A JP2000302661 A JP 2000302661A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- extract
- whitening effect
- carbon atoms
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
Abstract
(57)【要約】 (修正有)
【解決手段】 (A)カミツレ抽出物と、(B)営実及
び地楡の抽出物から選ばれる1種以上の植物エキスとを
含有する化粧料。更に成分(C):下記一般式(1)
[式中、R1は炭素数1〜16の直鎖又は分岐鎖のアル
キル基を、R2は水素原子、ヒドロキシル基又は炭素数
1〜6のアルコキシル基を示す]で表されるクロモン誘
導体を含有する化粧料。
【効果】 美白効果に優れる。(57) [Summary] (Corrected) [Solution] A cosmetic containing (A) an extract of chamomile and (B) one or more plant extracts selected from extracts of fruit and Jiyu. Further, component (C): the following general formula (1) [Wherein, R 1 represents a linear or branched alkyl group having 1 to 16 carbon atoms, and R 2 represents a hydrogen atom, a hydroxyl group or an alkoxyl group having 1 to 6 carbon atoms]. Contains cosmetics. [Effect] Excellent whitening effect.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、美白効果に優れた
化粧料に関する。TECHNICAL FIELD The present invention relates to a cosmetic having an excellent whitening effect.
【0002】[0002]
【従来の技術】皮膚のシミやソバカスは、一般に、日光
への曝露による刺激やホルモンの異常又は遺伝的要素を
原因としてメラノサイトが活性化され、その結果、メラ
ノサイトで合成されたメラニン色素が皮膚内に異常沈着
することにより発生すると言われている。2. Description of the Related Art Generally, skin spots and freckles are activated by melanocytes due to irritation caused by exposure to sunlight, hormonal abnormalities, or genetic factors. As a result, melanin synthesized by melanocytes is converted into melanocytes in the skin. It is said to be caused by abnormal deposition on the surface.
【0003】このようなシミ・ソバカスの防止には、従
来、L−アスコルビン酸及びその誘導体、ハイドロキノ
ン誘導体、コウジ酸及びその誘導体、胎盤抽出物等のメ
ラニン合成を抑制する成分を配合した美白化粧料が使用
されている。しかし、これらの物質はいずれも微弱なメ
ラニン抑制効果しか示さないため、それぞれ単独で化粧
料に配合した場合、十分な美白効果が得られなかった。[0003] In order to prevent such spots and freckles, a whitening cosmetic containing a component inhibiting melanin synthesis, such as L-ascorbic acid and its derivatives, hydroquinone derivatives, kojic acid and its derivatives, and placenta extract, has been conventionally used. Is used. However, all of these substances show only a weak melanin-suppressing effect. Therefore, when each of them is used alone in a cosmetic, a sufficient whitening effect cannot be obtained.
【0004】そこで、これらの物質に種々の植物抽出物
を組合わせ、美白効果を増強する試みがなされている。
例えば、コウジ酸及びその誘導体と、カミツレ、シコン
等の植物抽出物との組合せ(特開平3−236322号
公報)、ハイドロキノン配糖体と、クワ、アロエ等の生
薬エキスとの組合せ(特開平5−139950号公
報)、コウジ酸及びその誘導体と、エチナシ、オドリコ
ソウ等の植物エキスとの組合せ(特開平7−17846
号公報)、コウジ酸及びその誘導体と、アセロラ、イチ
ョウ等の植物エキスとの組合せ(特開平7−61915
号公報)等が挙げられる。しかしながら、これらの組合
わせにおいても美白増強効果は十分ではなく、満足すべ
きものは得られていない。Attempts have been made to enhance the whitening effect by combining these substances with various plant extracts.
For example, a combination of kojic acid or a derivative thereof with a plant extract such as chamomile or sicon (JP-A-3-236322), or a combination of a hydroquinone glycoside with a crude drug extract such as mulberry or aloe (JP-A-5-213) No. 139950), a combination of kojic acid and a derivative thereof with a plant extract such as gardenia and eucalypt (JP-A-7-17846).
Combination of Kojic acid and its derivatives with plant extracts such as acerola and ginkgo (JP-A-7-61915)
Publication). However, even with these combinations, the whitening enhancing effect is not sufficient, and a satisfactory one has not been obtained.
【0005】[0005]
【発明が解決しようとする課題】従って、本発明の目的
は、美白効果に優れた化粧料を提供することにある。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a cosmetic having an excellent whitening effect.
【0006】[0006]
【課題を解決するための手段】本発明者らは、カミツレ
抽出物と、営実又は地楡より抽出した植物エキスとを組
合せて用いれば、色素沈着を防止し優れた美白効果を示
す美白化粧料が得られることを見出した。SUMMARY OF THE INVENTION The present inventors have proposed a whitening cosmetic which exhibits excellent whitening effect by preventing pigmentation by using a chamomile extract in combination with a plant extract extracted from fruit or groundnut. Was obtained.
【0007】[0007]
【発明の実施の形態】本発明に用いる成分(A)カミツ
レ抽出物は、キク科植物であるカミツレ〔Matric
ariachamomillaL.(Composit
ae)〕の花を、水;メタノール、エタノール、プロパ
ノール、プロピレングリコール、1,3−ブタンジオー
ル等の親水性有機溶剤;ヒマシ油、パーシック油、大豆
油、ヒマワリ油、ミリスチン酸イソプロピル、ジカプリ
ン酸ネオペンチルグリコール、流動パラフィン、スクワ
ラン等の親油性有機溶剤、またはこれらの混合溶剤で抽
出することにより得ることができる。本発明において
は、こうして得られるカミツレ抽出物の1種以上を用い
ることができる。中でも、油溶性のカミツレ抽出物が優
れた美白効果を与えるので好ましく、特にスクワランを
用いた抽出物が好ましい。BEST MODE FOR CARRYING OUT THE INVENTION The component (A) chamomile extract used in the present invention is chamomile [Matric]
ariachamomillaL. (Composite
ae)] Flowers in water; hydrophilic organic solvents such as methanol, ethanol, propanol, propylene glycol, and 1,3-butanediol; castor oil, persic oil, soybean oil, sunflower oil, isopropyl myristate, and neo-dicaprate It can be obtained by extraction with a lipophilic organic solvent such as pentyl glycol, liquid paraffin, and squalane, or a mixed solvent thereof. In the present invention, one or more kinds of chamomile extract thus obtained can be used. Above all, an oil-soluble chamomile extract is preferable because it gives an excellent whitening effect, and an extract using squalane is particularly preferable.
【0008】かかるカミツレ抽出物には、一般に、カマ
ズレン、ウンベリフェロン、7−メトキシクマリン、マ
トリシン、マトリカリン、タラキサステロール、ウペオ
ール、アピイン、スピロエーテル化合物等が含まれてい
る。具体的には、特開平7−206657号公報記載の
スピロエーテル化合物が有効成分として挙げられる。[0008] Such chamomile extract generally contains camazulene, umbelliferone, 7-methoxycoumarin, matricin, matricalin, taraxasterol, upeol, apiin, spiroether compounds and the like. Specifically, spiro ether compounds described in JP-A-7-206657 are mentioned as active ingredients.
【0009】成分(A)の好ましい配合量は、化粧料全
量中に固形分として0.00001〜5重量%であり、
特に0.0005〜3重量%、更に0.001〜2重量
%配合すると、充分な美白効果が得られ、製品の保存安
定性にも優れる。[0009] A preferred amount of the component (A) is 0.00001 to 5% by weight as a solid content in the total amount of the cosmetic.
In particular, when 0.0005 to 3% by weight, more preferably 0.001 to 2% by weight, a sufficient whitening effect is obtained and the storage stability of the product is excellent.
【0010】本発明に用いる成分(B)の植物エキスの
うち、営実エキス(Rose Fruit Extract)は、バラ科の
ノイバラ(Rose multiflora Thunberg)又はその近縁種
の果実から抽出することによって得ることができる。[0010] Among the plant extracts of the component (B) used in the present invention, the fruit extract (Rose Fruit Extract) can be obtained by extracting from the fruit of rose multiflora Thunberg or a closely related species thereof. it can.
【0011】また、地楡エキス(Burnet Extract)は、
バラ科のワレモコウ(Sangui sorbaofficinalis Linn
e)又はその変種の根又は根茎から抽出することによっ
て得ることができる。[0011] In addition, Burnu Extract is
Rose moth (Sangui sorbaofficinalis Linn)
e) or a variant thereof by extraction from the roots or rhizomes.
【0012】本発明の化粧料中の、これら成分(B)の
植物エキスの含有量は、美白効果及び保存安定性の点か
ら、化粧料全量中に固形分として0.00001〜5重
量%、特に0.0005〜3重量%、更に0.001〜
2重量%が好ましい。The content of the plant extract of the component (B) in the cosmetic of the present invention is preferably 0.00001 to 5% by weight as a solid content in the total amount of the cosmetic from the viewpoint of whitening effect and storage stability. Especially 0.0005 to 3% by weight, more preferably 0.001 to
2% by weight is preferred.
【0013】本発明の化粧料には、更に成分(C)とし
て、下記一般式(1)で表されるクロモン誘導体を配合
すると、美白効果が増強されるので好ましい。It is preferable that the cosmetic of the present invention further contains a chromone derivative represented by the following general formula (1) as the component (C), since the whitening effect is enhanced.
【0014】[0014]
【化2】 Embedded image
【0015】〔式中、R1 は炭素数1〜16の直鎖又は
分岐鎖のアルキル基を、R2 は水素原子、ヒドロキシル
基又は炭素数1〜6のアルコキシル基を示す〕Wherein R 1 represents a linear or branched alkyl group having 1 to 16 carbon atoms, and R 2 represents a hydrogen atom, a hydroxyl group or an alkoxyl group having 1 to 6 carbon atoms.
【0016】一般式(1)で表される化合物のうち、特
にR1 が炭素数4〜9の直鎖又は分岐鎖のアルキル基
で、R2 が水素原子、ヒドロキシル基又はメトキシ基の
ものが好ましい。これらの化合物は1種以上を用いるこ
とができる。Among the compounds represented by the general formula (1), those in which R 1 is a linear or branched alkyl group having 4 to 9 carbon atoms and R 2 is a hydrogen atom, a hydroxyl group or a methoxy group preferable. One or more of these compounds can be used.
【0017】成分(C)を使用する場合、その含有量
は、化粧料全量中に0.01〜20重量%が好ましく、
特に0.1〜10重量%、更に0.1〜5重量%が、美
白効果が増強され使用感も良好となるため好ましい。When the component (C) is used, its content is preferably 0.01 to 20% by weight based on the total amount of the cosmetic.
In particular, 0.1 to 10% by weight, more preferably 0.1 to 5% by weight is preferable because the whitening effect is enhanced and the feeling in use is improved.
【0018】本発明の化粧料には、更に、紫外線吸収剤
及び紫外線散乱剤から選ばれる1種以上を配合すると、
日焼けによるメラニン生成を抑制することができるので
好ましい。かかる紫外線吸収剤及び紫外線散乱剤として
は特に限定されず、通常用いられる油溶性または水溶性
の紫外線吸収剤、紫外線散乱剤のいずれをも好適に用い
ることができる。When the cosmetic of the present invention further contains one or more selected from an ultraviolet absorber and an ultraviolet scattering agent,
This is preferable because the production of melanin due to sunburn can be suppressed. The ultraviolet absorber and the ultraviolet scattering agent are not particularly limited, and any of oil-soluble or water-soluble ultraviolet absorbers and ultraviolet scattering agents that are commonly used can be suitably used.
【0019】中でも、オクチルジメチル−p−アミノ安
息香酸、2−エチルヘキシル−p−メトキシシンナメー
ト、4−メトキシ−4' −t−ブチルジベンゾイルメタ
ン、1−(3,4−ジメトキシフェニル)−4,4−ジ
メチル−1,3−ペンタンジオン、2−ヒドロキシ−4
−メトキシベンゾフェノン等の紫外線吸収剤;酸化亜
鉛、酸化チタン、酸化鉄等の紫外線散乱剤が好ましい。
これらの成分を使用する場合、その含有量は、化粧料全
量中に0.001〜30重量%が好ましく、特に0.0
1〜30重量%、更に0.05〜20重量%が好まし
い。Among them, octyldimethyl-p-aminobenzoic acid, 2-ethylhexyl-p-methoxycinnamate, 4-methoxy-4'-t-butyldibenzoylmethane, 1- (3,4-dimethoxyphenyl) -4 , 4-Dimethyl-1,3-pentanedione, 2-hydroxy-4
UV absorbers such as methoxybenzophenone; UV scattering agents such as zinc oxide, titanium oxide and iron oxide are preferred.
When these components are used, the content thereof is preferably 0.001 to 30% by weight based on the total amount of the cosmetic, and particularly preferably 0.03% by weight.
It is preferably 1 to 30% by weight, more preferably 0.05 to 20% by weight.
【0020】本発明の化粧料には、上記の成分の他に通
常化粧品や医薬部外品、医薬品等に用いられる各種任意
成分を必要に応じて適宜配合することができる。例えば
水、エタノール、油性成分、保湿剤、増粘剤、防腐剤、
乳化剤、薬効成分、粉体、着色剤、香料、乳化安定剤、
pH調整剤等が挙げられる。In the cosmetic of the present invention, in addition to the above-mentioned components, various optional components usually used in cosmetics, quasi-drugs, pharmaceuticals and the like can be appropriately compounded as required. For example, water, ethanol, oily components, humectants, thickeners, preservatives,
Emulsifier, medicinal ingredient, powder, colorant, fragrance, emulsion stabilizer,
pH adjusters and the like.
【0021】本発明の化粧料は、常法に従って製造する
ことができる。また、本発明の化粧料は、一般の皮膚化
粧料に限定されるものではなく、医薬部外品、外用医薬
品等を包含するものであり、その剤型も目的に応じて任
意に選択することができる。即ち、クリーム、軟膏、乳
液、溶液、ゲル等の剤型や、パック、ローション、パウ
ダー、スティック等の形態とすることができる。The cosmetic of the present invention can be produced according to a conventional method. In addition, the cosmetic of the present invention is not limited to general skin cosmetics, but includes quasi-drugs, topical drugs, and the like, and its dosage form may be arbitrarily selected according to the purpose. Can be. That is, it can be in the form of a cream, ointment, emulsion, solution, gel or the like, or in the form of a pack, lotion, powder, stick or the like.
【0022】[0022]
【発明の効果】本発明の化粧料は、色素沈着を防止し優
れた美白効果を示すので、日焼け等によるシミ・ソバカ
スを防止する化粧料として使用することができる。The cosmetic of the present invention prevents pigmentation and exhibits an excellent whitening effect, so that it can be used as a cosmetic for preventing spots and freckles due to sunburn.
【0023】[0023]
【実施例】実施例1〜4及び比較例1〜5 表2に示す組成のクリームを製造し、その美白効果につ
いて評価した。結果を表2に示す。EXAMPLES Examples 1 to 4 and Comparative Examples 1 to 5 Creams having the compositions shown in Table 2 were produced and evaluated for their whitening effect. Table 2 shows the results.
【0024】(製法)表2中の油相成分を混合して80
℃で加熱溶解し、これに60℃に加熱した水相成分を攪
拌しながら加え、更に攪拌下室温まで冷却して、クリー
ムを得た。(Preparation method) The oil phase components shown in Table 2 were mixed and mixed.
The resulting mixture was heated to 60 ° C. and dissolved therein, and the aqueous phase component heated to 60 ° C. was added thereto with stirring, and further cooled to room temperature with stirring to obtain a cream.
【0025】(UV−B誘導色素斑に対する美白効果試
験)被験者20名の上腕内側部に、UV−B領域の紫外
線を最小紅斑量の2倍量を1日1回、2日間にわたり照
射して誘導した色素斑に、試料を連続塗布(1日2回、
1ケ月間)することにより美白効果を調べた。評価は、
色差計(村上色彩製CMS−1200)を用いて測色を
行い、得られたマンセル値よりL* 値を算出し、その回
復を表すΔΔL* 値を用いた。ΔΔL* 値は以下の式で
定義する。即ち、試料塗布開始直前の被験部位及び試料
未塗布の被験部位のL* をそれぞれL0、L0' 、連続
塗布1ケ月後の各々の部位のL* 値をそれぞれL1、L
1' として、以下の式で算出される数値をΔΔL* とす
る。 ΔΔL* =(L1−L0)−(L1'−L0') 結果は表1に示す区分により、被験者それぞれのΔΔL
* 値に対応する評価点を求め、20名の平均値で表2中
に示した。(Whitening Effect Test for UV-B-Induced Pigmented Spots) Twenty test subjects were irradiated with the UV-B region ultraviolet rays twice the minimum erythema amount once a day for 2 days. A sample is continuously applied to the induced pigment spots (twice a day,
(One month) to examine the whitening effect. Evaluation,
Colorimetry was performed using a color difference meter (CMS-1200 manufactured by Murakami Color Co., Ltd.), L * value was calculated from the obtained Munsell value, and ΔΔL * value indicating the recovery was used. The ΔΔL * value is defined by the following equation. That is, L * of the test site immediately before the start of sample application and L * of the test site where no sample was applied were L0 and L0 ', respectively, and L * value of each site one month after continuous application was L1 and L, respectively.
As 1 ′, a numerical value calculated by the following equation is ΔΔL *. ΔΔL * = (L1−L0) − (L1′−L0 ′) The results are shown in Table 1.
* Evaluation points corresponding to the values were obtained and shown in Table 2 by the average value of 20 persons.
【0026】[0026]
【表1】 [Table 1]
【0027】[0027]
【表2】 [Table 2]
【0028】表2の結果より、本発明のクリームは、成
分(A)と(B)の配合により、美白効果が相乗的に向
上していることがわかる。From the results in Table 2, it can be seen that the cream of the present invention synergistically improved the whitening effect by the combination of the components (A) and (B).
───────────────────────────────────────────────────── フロントページの続き (72)発明者 楠奥 比呂志 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 (72)発明者 渋谷 祐輔 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 (72)発明者 八谷 輝 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 (72)発明者 小林 明美 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 Fターム(参考) 4C083 AA111 AA112 AB242 AC022 AC072 AC122 AC302 AC312 AC392 AC422 AC532 AC841 AC842 AD162 CC05 DD31 EE16 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hiroshi Kusunoki 2606 Kabane-cho, Akaga-cho, Haga-gun, Tochigi Prefecture, Japan Kao Co., Ltd. (72) Inventor Yusuke Shibuya 2606, Kabashi-cho, Akabane, Haga-gun, Tochigi Prefecture, Kao Corporation (72) Inventor Akira Hachiya 2606 Kabane-cho, Akaga-cho, Haga-gun, Tochigi Pref. In Kao Co., Ltd. (72) Inventor Akemi Kobayashi 2606, Kabachi-cho, Akaga-cho, Haga-gun, Tochigi Pref. Kao Co., Ltd. AB242 AC022 AC072 AC122 AC302 AC312 AC392 AC422 AC532 AC841 AC842 AD162 CC05 DD31 EE16
Claims (3)
び地楡の抽出物から選ばれる1種以上の植物エキスとを
含有する化粧料。1. A cosmetic containing (A) an extract of chamomile and (B) one or more plant extracts selected from extracts of fruit and Jiyu.
キル基を、R2 は水素原子、ヒドロキシル基又は炭素数
1〜6のアルコキシル基を示す〕で表されるクロモン誘
導体を含有する請求項1記載の化粧料。2. Component (C): The following general formula (1): [Wherein, R 1 represents a linear or branched alkyl group having 1 to 16 carbon atoms, and R 2 represents a hydrogen atom, a hydroxyl group or an alkoxyl group having 1 to 6 carbon atoms]. The cosmetic according to claim 1, which contains.
られたカミツレ抽出物である請求項1または2記載の化
粧料。3. The cosmetic according to claim 1, wherein the component (A) is a chamomile extract obtained by extraction with squalane.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11112972A JP2000302661A (en) | 1999-04-21 | 1999-04-21 | Cosmetics |
| TW89105229A TWI253937B (en) | 1999-04-21 | 2000-03-22 | Cosmetics containing extract of chamomile and one or more kinds of plant extracts of dog rose fruits and brunet |
| CNB001069233A CN1161092C (en) | 1999-04-21 | 2000-04-21 | cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11112972A JP2000302661A (en) | 1999-04-21 | 1999-04-21 | Cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000302661A true JP2000302661A (en) | 2000-10-31 |
Family
ID=14600180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11112972A Pending JP2000302661A (en) | 1999-04-21 | 1999-04-21 | Cosmetics |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2000302661A (en) |
| CN (1) | CN1161092C (en) |
| TW (1) | TWI253937B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040043971A (en) * | 2002-11-20 | 2004-05-27 | 동방에프티엘 주식회사 | Extract compositions comprising a natural phellinus linteus, green tea, caryophilli flos and rosae fructus and cosmetic products comprising their extracts |
| JP2015117221A (en) * | 2013-12-20 | 2015-06-25 | 一丸ファルコス株式会社 | Stem cell activation agent |
| US9227090B2 (en) | 2008-06-18 | 2016-01-05 | Conopco, Inc. | Method for lightening skin |
| JP7594051B2 (en) | 2020-04-30 | 2024-12-03 | 富士フイルム株式会社 | Bone morphogenetic protein 4 inhibitor |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH07188208A (en) * | 1993-12-27 | 1995-07-25 | Kao Corp | Topical skin |
| JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetics |
| JPH08119825A (en) * | 1994-10-20 | 1996-05-14 | Ichimaru Pharcos Co Ltd | Hydroxytyrosol, application for skin external medicine or bathing agent |
| JPH10265321A (en) * | 1997-03-19 | 1998-10-06 | Shiseido Co Ltd | Skin preparation for external use |
| JPH1129430A (en) * | 1997-05-14 | 1999-02-02 | Kao Corp | Cosmetics |
-
1999
- 1999-04-21 JP JP11112972A patent/JP2000302661A/en active Pending
-
2000
- 2000-03-22 TW TW89105229A patent/TWI253937B/en not_active IP Right Cessation
- 2000-04-21 CN CNB001069233A patent/CN1161092C/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH07188208A (en) * | 1993-12-27 | 1995-07-25 | Kao Corp | Topical skin |
| JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetics |
| JPH08119825A (en) * | 1994-10-20 | 1996-05-14 | Ichimaru Pharcos Co Ltd | Hydroxytyrosol, application for skin external medicine or bathing agent |
| JPH10265321A (en) * | 1997-03-19 | 1998-10-06 | Shiseido Co Ltd | Skin preparation for external use |
| JPH1129430A (en) * | 1997-05-14 | 1999-02-02 | Kao Corp | Cosmetics |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040043971A (en) * | 2002-11-20 | 2004-05-27 | 동방에프티엘 주식회사 | Extract compositions comprising a natural phellinus linteus, green tea, caryophilli flos and rosae fructus and cosmetic products comprising their extracts |
| US9227090B2 (en) | 2008-06-18 | 2016-01-05 | Conopco, Inc. | Method for lightening skin |
| JP2015117221A (en) * | 2013-12-20 | 2015-06-25 | 一丸ファルコス株式会社 | Stem cell activation agent |
| JP7594051B2 (en) | 2020-04-30 | 2024-12-03 | 富士フイルム株式会社 | Bone morphogenetic protein 4 inhibitor |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI253937B (en) | 2006-05-01 |
| CN1161092C (en) | 2004-08-11 |
| CN1272360A (en) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI293888B (en) | Cosmetic composition | |
| JP3135943B2 (en) | Whitening agent | |
| JP2764510B2 (en) | Whitening cosmetics | |
| JP4464533B2 (en) | Cosmetics | |
| JP2000198712A (en) | Cosmetic composition | |
| JP2000143479A (en) | Whitening cosmetics | |
| JP3195684B2 (en) | Skin cosmetics | |
| JPH10265322A (en) | Skin preparation for external use | |
| JP2000302661A (en) | Cosmetics | |
| JP3195683B2 (en) | Skin cosmetics | |
| JP3052104B2 (en) | Skin cosmetics | |
| JP2001010926A (en) | Bleaching agent | |
| JPH0672849A (en) | Skin color-lightening cosmetic | |
| JP3188021B2 (en) | Skin cosmetics | |
| JPH08283136A (en) | Wrinkle formation inhibitor | |
| JP2000256175A (en) | Cosmetic composition | |
| JP2010150237A (en) | Ceramide production promotor, and pharmaceutical formulation, external preparation for skin, cosmetic composition and cosmetic product, using the ceramide production promotor | |
| JPH09157151A (en) | Melanin generation inhibitor and whitening agent | |
| JP2002234828A (en) | Skin whitening cosmetic preparation | |
| JP2001114664A (en) | Cosmetic | |
| KR100431271B1 (en) | Composition for skin whitening containing Arecoline | |
| JP4037836B2 (en) | Hyaluronidase activity inhibitor | |
| JP4762477B2 (en) | Topical skin preparation | |
| JPH04356416A (en) | Skin cosmetic | |
| JP3317735B2 (en) | Skin cosmetics for erythema control and pigmentation control |